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Development of tissue engineering scaffolds relies on careful selection of pore architecture and
chemistry of the cellular environment. Repair of skeletal soft tissue, such as tendon, is partic-
ularly challenging, since these tissues have a relatively poor healing response. When removed
from their native environment, tendon cells (tenocytes) lose their characteristic morphology
and the expression of phenotypic markers. To stimulate tendon cells to recreate a healthy ex-
tracellular matrix, both architectural cues and fibrin gels have been used in the past, however,
their relative effects have not been studied systematically. Within this study, a combination of
collagen scaffold architecture, axial and isotropic, and fibrin gel addition was assessed, using
ovine tendon-derived cells to determine the optimal strategy for controlling the proliferation
and protein expression. Scaffold architecture and fibrin gel addition influenced tendon cell
behavior independently in vitro. Addition of fibrin gel within a scaffold doubled cell number
and increased matrix production for all architectures studied. However, scaffold architecture
dictated the type of matrix produced by cells, regardless of fibrin addition. Axial scaffolds,
mimicking native tendon, promoted a mature matrix, with increased tenomodulin, a marker for
mature tendon cells, and decreased scleraxis, an early transcription factor for connective tissue.
This study demonstrated that both architectural cues and fibrin gel addition alter cell behavior
and that the combination of these signals could improve clinical performance of current tissue
engineering constructs.
1 Introduction
Like many connective tissues, the functional properties of tendon are defined by the native
extra-cellular matrix (ECM) laid down by the cells. Within healthy tissue, tendon is composed
of a highly ordered matrix of collagen fibers, designed to transmit load from the muscle to the
bone and to act as an elastic spring [1, 2]. In addition to a dense ECM, tendon tissue contains
elongated cells, thought to repair and maintain the matrix of collagen fibers [3].
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Adult connective tissues, such as tendon, are often considered deficient in terms of healing
potential, and, after injury, the restored ECM is often unaligned fibrocartilage, lacking the
mechanical properties or matrix composition of undamaged tissue [4]. While it has been shown
that the growth of mature tendon cells decreases with age, the response to growth factors, and
the ability of cells to produce collagen Type I fibrils in vitro remains unaffected [4, 5]. Thus,
it may be a lack of environmental cues, such as reduced cell density or lack of growth factors,
rather than an inability to activate the appropriate cell machinery, which causes the poor healing
response [5].
Tissue engineering of tendon, to direct cell response and recreate the unique properties of
healthy tissue, has focused on providing external signals to stimulate cells to produce char-
acteristic, aligned ECM in vitro using either scaffolds or fibrin gels. An advantage of scaffolds
is the ability to incorporate architectural cues, which can promote tendon cell elongation. In
collagen scaffolds with an aligned pore architecture, tendon cells can be stimulated to produce
an ECM more characteristic of tendon than on non-aligned scaffolds [6]. Likewise, fibrin gels,
a component of the natural clotting system, can be used as support structures which allow ten-
don cells to align and elongate [7–9]. Unlike other gel systems, fibrin does not inhibit ECM
formation, and the resulting matrix is composed of aligned collagen fibers, mimicking that in
healthy tissue [5, 10]. However, neither approach is perfect. It is difficult for cells to penetrate
to the interior of collagen scaffolds, and fibrin gels are prone to instability if the dissolution of
the gel is not matched by ECM production of the entrapped cells [6, 10].
With the addition of fibrin gels to scaffolds, tissue engineering outcomes, such as in vitro blood
vessel formation and osteogenic differentiation, have been shown to improve [11, 12]. While
the advantage of adding fibrin to tissue engineering constructs is clear, the effects of combining
fibrin gel and architectural cues has, to our knowledge, never been examined. Understanding
the influence of each element within tissue engineering constructs is important in order to
improve clinical outcomes, and we hypothesized that scaffold architecture would continue to
influence tendon cell behavior, even in the presence of a fibrin gel.
Control over the incorporation of architectural cues into collagen scaffolds has been elucidated
previously, and two distinct scaffold architectures were examined within this study [13, 14].
Aligned architecture, mimicking the native collagen orientation in native tendon, was com-
pared to a homogeneous, isotropic scaffold with no preferred pore orientation. Both scaffold
types were assessed with and without fibrin gel addition and compared to a fibrin only control.
The biological activity of tendon tissue engineering constructs is described by two key features:
their ability to stimulate cell growth and to allow cells to recreate an ECM which matches the
native healthy tissue. Thus, throughout the study, cellular proliferation and metabolic activity
were monitored and the composition of the matrix produced within the tissue engineering con-
structs was evaluated using western blotting. By understanding the independent and specific
roles of collagen scaffold architecture and fibrin gel addition, better strategies can be developed
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to maximize the healing potential of adult cells.
2 Methods
2.1 Scaffold Production
Unless noted, reagents came from Sigma, UK. Suspensions of 1 wt% collagen were prepared by
hydrating insoluble bovine Achilles tendon, Type I collagen (Sigma Aldrich) in 0.05M acetic
acid, adjusted to pH 2. Slurries were homogenized (VDI 25, VWR International Ltd, UK) at
13,500 rpm for 30 minutes in an ice water bath , and centrifuged (Hermle Z300) for 5 minutes
at 2500 rpm.
Specialized molds were used to alter collagen scaffold architecture. To create axial scaffolds,
perspex molds with a 3mm plate of copper at the base were used; the inner diameter of the
molds was 8 mm and the height 28 mm [15]. The mold for isotropic scaffolds was constructed
from 2 mm thick stainless steel with an inner diameter of 45 mm [15]. During freeze-drying, the
slurry was cooled, at a rate of 0.9 °C/min, to -30 °C and held for 90 minutes, then lyophilized
using a Virtis freeze drier (SP Industries, USA) at 0 °C for 20 hours under a vacuum of less
than 100 mTorr. Scaffolds were cross-linked for 4 hours in a 70% ethanol solution containing
a 5:2:1 ratio of N-(3-Dimethylamino propyl)-N’-ethylcarbodiimide hydrochloride (EDC): N-
Hydroxysuccinimide (NHS): collagen COOH groups [16].
2.2 Tendon-Derived Cell Isolation
Ovine primary patellar tendon-derived cells were harvested by digesting minced tissues for
2 hours at 37°C in 0.2% collagenase (Roche) in complete media (10% fetal bovine serum,
2mM glutamine, 1ug/ml penicillin/streptomycin, 0.001 ug/ml Amphotericin, 0.01 ug/ml gen-
tamycin). The resulting cell suspension was washed once in complete media, resuspended and
plated in monolayer culture. Tendon derived cells were used between passages 4 and 5.
2.3 Cell Culture
Tissue culture polystyrene (TCPS) plates were coated in SYLGARD (type 184 silicone elas-
tomer, Dow Chemical) and set overnight at 60°C [7]. For sterilization, plates were soaked
overnight in 70% ethanol. Scaffolds were pinned to the SYLGARD with minutiens insect pins
(0.1 mm diameter, Fine Science Tools GmbH, Germany), one on either side of each scaffold
and sterilized by immersion in 70% ethanol for one hour, then washing twice in 1x phosphate
buffered saline (PBS). Before seeding cells, PBS was replaced with either media, for samples
without fibrin, or with PBS, for samples with fibrin.
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Immediately before seeding cells, scaffolds were blotted in situ with sterilized filter paper
(3MM, Whatman). Fibrin gels were prepared by adding 1% fibrin and aprotinin (0.15 U/ml) to
PBS. Scaffolds were seeded with 1x106 tendon cells in 75 µl of either media or fibrin. Scaf-
folds without fibrin gel were incubated (5% CO2, 37 °C) for 2 hours before flooding the well
with complete media. For scaffolds with fibrin gels, immediately after addition of suspension,
scaffolds were immersed in 300 μl of 0.4 U/ml thrombin and allowed to set for 10 minutes.
Excess thrombin was removed and replaced with complete media. Empty, control scaffolds
were treated as other scaffolds, but with media or fibrin which did not contain cells. The fib-
rin control, adapted from Kapacee et al [7], was constructed by seeding 1x106 cells in 75 µl
of fibrin across a 10 mm gap between minutiens pins. The fibrin control was gelled in 75 µl
of 0.4 U/ml thrombin. To compare to the fibrin control, all scaffolds were 10 mm in length,
with a cross-section of 5x5 mm. The samples groups were: axial (AX), axial+fibrin (AX(F+)),
isotropic (ISO), isotropic+fibrin (ISO(F+)), and fibrin (F+).
2.4 Cell Metabolic Assay
An alamarBlue® assay (Invitrogen, UK) was used to test cell metabolism on days 3, 10, and
17. Samples were incubated in media containing 10% alamarBlue. Cells were incubated for 4
hours at 37 °C. The fluorescence of the cell supernatant was read using a Fluorstar optima plate
reader (BMG Labtech).
2.5 Cell Number
The number of cells attached to the constructs was measured using DNA concentration, which
was evaluated via the Hoechst assay after 7, 14 and 21 days [17]. Cells and scaffolds were
digested at 60°C overnight in papain buffer [18]. Briefly, 10 µl of papain digest was added to
Hoechst dye (Bisbenzimide H) for a final dye concentration of 0.1 µg/ml. Fluorescence was
measured on a Fluorstar Optima plate reader (360nm Ex, 460nm Em).
2.6 Matrix Production
Protein expression at 21 days was analyzed using SDS-PAGE and Western blotting. Con-
structs were incubated overnight at 4 ºC in cell lysis buffer (Invitrogen) and mixed with sodium
dodecyl-sulphate (SDS) sample buffer for a final concentration of 1x, before incubation at 60
°C for 20 minutes. Standards were prepared from native ovine patellar tendon tissue, which
was snap frozen in liquid nitrogen, milled using a dismembrator (B Braun Biotech Interna-
tional GmbH), and suspended in cell lysis buffer (100mg/ml).
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A Novex assembly with commercially available 4-20% Tris-glycine gels (Invitrogen) was used.
Proteins were separated (125 V for 2 hours), and were transferred to a membrane (Immobilon
PVDF, Millipore) for Western blotting. Tendon constructs were probed for fibronectin (SC-
9068, Santa Cruz Biotech), tenascin-C (ab82449 Abcam), tenomodulin (ab81328 Abcam),
scleraxis (OAAB00449 Aviva Sys Biology), and collagen Type I (Rockland). Peroxidase sec-
ondary antibodies were used throughout.
After immunoprobing, membranes were developed using ECL plus reagents (Amersham), per
manufacturer’s instructions. Signal strength was assessed using a densitometer (BioRad GS-
800). All data is represented as the fold change from the axial scaffold without fibrin. Within
each sub-figure, all of the lanes are from the same gel; where lanes have been moved for clarity,
it has been clearly marked. Data was normalized by DNA concentration due to interference of
serum proteins with protein normalization (data not shown).
2.7 Immunohistochemical Staining
Constructs were frozen in OCTTM Compound (Tissue Tek) and sectioned into 10µm slices with
a microtome (Bright, UK). Tissue sections were fixed in 1:1 acetone-methanol, and washed in
PBS-0.1% Tween. Sections were incubated with a fibronectin antibody (SC-9068, Santa cruz
Biotech) at 1:200 dilution in PBS-tween for 4 hours, and placed in FTIC-conjugated secondary
antibodies for 1 hour. Sections were mounted with Vectashield+DAPI (Vector Labs).
2.8 Scanning Electron Microscopy
All scanning electron microscopy images were taken using a JEOL 820, with a tungsten source,
operated at 10 kV. For images of cells on scaffolds, cells were fixed for 1 hour in 4% paraformalde-
hyde and samples were dried by soaking for 20 minutes in ethanol dilutions, modified from
[19]. The ethanol dilutions were as follows: 25%, 30%, 50%, 70%, 80%, and 90% ethanol.
Scaffolds were then washed twice, in 100% ethanol, and transferred to a 50/50 v/v mixture of
ethanol and Hexamethyldi-silazane (HDMS), before replacing the solution with 100% HDMS.
Samples were allowed to air dry overnight. All sections of the collagen scaffolds were sputter
coated with platinum, at a current of 40 mA prior to imaging.
2.9 Statistics
Metabolic activity had a sample size of 8, and 3 replicates were used for cell number studies.
All western blots were run with three replicates. Groups were compared with ANOVA followed
by a post-hoc Tukey HSD test, with a 95% confidence interval. All data is presented with
standard deviations.
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Figure 1: Structure differed markedly between axial and isotropic scaffolds. Axial scaffolds
had no preferred orientation in the (a) transverse direction, but consisted of (b) aligned pores in
the longitudinal direction, running from the scaffold base to the top. Isotropic scaffolds were
had no preferred orientation in any direction, but had the same structure in the (c) longitudinal
and (d) transverse direction. Upon hydration, (e) axial scaffolds and (f) isotropic scaffolds had
a similar pore size. Scale bar is 100μm.
3 Results
3.1 Scaffold Architecture
Two different structures were formed: axial and isotropic scaffolds (Fig. 1). Axial scaffolds, as
has been demonstrated previously in the literature, consisted of aligned pores in the longitudinal
direction (Fig. 1a), while in the transverse plane, there was no predominant directionality of
the pores (Fig. 1b) [6]. Isotropic scaffolds consisted of purely equiaxed pores with no preferred
orientation (Fig. 1c, d). In the hydrated state, the pore size of the scaffolds appeared similar
(Fig. 1e, f). Both scaffold types have a pore size of between 100 – 130 μm, as shown in
a previous study [15]. Tendon cells were found to adhere on all scaffold constructs tested,
regardless of scaffold structure (Fig. 2). With the addition of fibrin gels to collagen scaffolds,
cell number increased visibly, and tendon cells appeared more well spread on the cross-linked
collagen surface (Fig. 2c, d).
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Figure 2: Tendon cells could adhere to all scaffold constructs: (a) axial scaffold, (b) isotropic
scaffold, (c) axial scaffold with fibrin, (d) isotropic scaffold with fibrin. With fibrin gel addition,
the cells appeared well spread. Scale bar is 20μm.
3.2 Cellular Metabolic Activity and Number
Cell metabolic activity increased significantly in all scaffolds over a three week period (Fig. 3).
After 21 days, there were no significant differences between cell metabolic activity on isotropic
or axial scaffolds . While scaffold architecture produced no significant changes in metabolic
activity, fibrin addition to scaffolds increased cell metabolic activity above that of scaffolds
alone (Fig. 3a). A significant decrease was observed in the cell metabolic activity in the fibrin
control (Fig. 3a).
Cell number remained relatively constant over the culture period. There was no significant
difference between cell number on axial and isotropic architectures after three weeks, even in
the presence of a fibrin gel. However, the addition of a fibrin gel to scaffolds increased sell
number significantly, even above the fibrin control (Fig. 3b).
3.3 Extra Cellular Matrix Production
The final outcome of the constructs was assessed via Western blotting after 21 days in culture
and normalized via DNA concentration to determine relative matrix production independent of
cell proliferation within the constructs. Constructs were assessed for fibronectin, scleraxis, and
tenomodulin, which are accepted markers of tendon phenotype [20]. Tenascin-C expression
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Figure 3: The effect of scaffold architecture and fibrin gel addition on (a) metabolic activity as
measured by the alamarBlue assay and (b) cell number evaluated using the Hoechst assay. *
Significantly greater than the fibrin control (p < 0.05). # Significantly different from all other
sample types (p < 0.05).
was also evaluated, but it was found that none of the constructs had strong expression of the
protein, so further quantification was not performed. In addition to tendon specific phenotype
markers, fibronectin was used as a general marker of cellular attachment to scaffold structures.
All protein expression was reported as a fold change from axial scaffolds without fibrin.
Fibronectin
Fibronectin was found to be specific to cellular activity and was not expressed in empty scaf-
folds (Figure 4a). Fibronectin is known to be dimeric with a calculated molecular weight of
220 kDa (monomer) [21]. Faint bands at 220 kDa were visible with a stronger band at roughly
440 kDa, suggesting that most of the fibronectin was dimerized.
The amount of fibronectin appeared to vary with scaffold architecture. Cells on isotropic scaf-
folds produced greater amounts of fibronectin than on axial scaffolds. This trend was true
with and without fibrin gel addition. Immunohistochemistry on axial and isotropic scaffolds
revealed that the majority of fibronectin within the matrix was located along scaffold edges,
(Fig. 5). The addition of fibrin gel to scaffolds resulted in a lower fibronectin expression (Fig.
4c).
Collagen Type I
Even though the scaffolds themselves were made of collagen Type I fibers, the empty scaffolds
had no visible signal when the antibody was tested (Fig. 4d), likely because the collagen of
the scaffold was not soluble in the lysis buffer used to extract the ECM, being made from acid
insoluble collagen which has mature cross-links [22]. Bands, corresponding to the alpha 1(I)
and alpha 2(I) chains of collagen, were seen at 139 kDa and 129 kDa, respectively [23]. The
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Figure 4: Protein expression differed with architecture and addition of fibrin for (a-c) fi-
bronectin, (d-f) collagen Type I, (g-i) scleraxis, and (j-m) tenomodulin. (a, d, g, j) Protein
expression was specific to cells. 1: AX; 2: empty AX; 3: ISO; 4: empty ISO; 5: AX(F+); 6:
empty AX(F+); 7: ISO(F+); 8: empty ISO(F+); 9: (F+); 10: empty (F+); 11: tendon tis-
sue. (b, e, h, k) Protein expression varied with the sample type. A: AX; B: ISO; C: AX(F+);
D: ISO(F+); E: fibrin. (c, f, i, m) Protein expression presented as the fold change from AX
scaffold, measured via densitometry.
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Figure 5: Immunohistochemistry staining of tendon cells for fibronectin in (a) axial scaffolds,
(b) isotropic scaffolds, (c) axial scaffolds + fibrin, and (d) isotropic scaffolds + fibrin. Blue is
DAPI nuclear stain, green is fibronectin. Magnification is 20x.
bands above 220 kDa, multimers of the alpha chains, produced a much stronger signal. Native
tendon tissue had a smear of low molecular weight fragments, probably due to degradation
of the collagen during processing (Fig 4d, lane 11). Tendon cells formed collagen Type I in
all scaffold orientations and culture systems (Fig. 4e). There was no difference in expression
between axial or isotropic scaffolds, or even with the addition of a fibrin gel once the protein
expression was normalized by DNA content (Fig 4f).
Scleraxis
Blots of scleraxis showed bands at 30, 35, and 42 kDa, with an occasional unreducible band at
higher molecular weights (Fig. 4g). As a transcription factor associated with connective tissue,
scleraxis has a predicted size of roughly 22 - 28 kDa [20, 24]. However, within this study,
scleraxis was found in unreducible bands at 37 and 42 kDa, which are not reported in litera-
ture. While the antibody is well characterized and commercially manufactured, it is not known
whether isoforms of scleraxis exist, or the precise mechanism of scleraxis regulation, especially
in ovine models [25,26]. No scleraxis expression was detected from native tendon tissue at any
point, even though adult tissues have been shown to express scleraxis mRNA throughout life
and that gene expression can be induced in adults with exercise [27,28]. However, these studies
have been based on gene expression levels rather than protein expression, and it is possible that
the protein levels produced in the adult tissue are below detection limits.
Scleraxis signal came from cellular activity (Fig. 4g), but, interestingly, no signal for scleraxis
was ever seen in native tendon tissue, although cells expressed scleraxis in all tendon constructs.
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Cells on isotropic scaffolds had a greater scleraxis expression than axial scaffolds(Fig. 4i). This
effect of architecture remained, even with the addition of fibrin. However, the addition of fibrin
to scaffolds increased the scleraxis expression within constructs (Fig. 4i). The 30 kDa band,
reported in literature, only appeared when cells were cultured in scaffolds with fibrin (Fig. 4h).
While the mean expression level of scleraxis was lower in fibrin gel than in any other construct,
the variability was high.
Tenomodulin
In native tendon tissue, tenomodulin bands were found at 35, 95, and 220 kDa (Fig. 4j). Within
scaffolds, most tenomodulin signal was detected in two bands around 40 kDa, and in another
doublet at 220 kDa and higher. Tenomodulin expression was higher on axial scaffolds than
on isotropic scaffolds (Fig. 4m), which was clearly visible after fibrin gel addition. The ad-
dition of fibrin to scaffolds caused an increase in tenomodulin expression. Fibrin gel on its
own appeared to stimulate tenomodulin expression, however, the degree of up-regulation was
highly variable between samples. Bands were detected at approximately the predicted molecu-
lar weight of tenomodulin, but there were also bands at higher molecular weights [24, 29, 30].
Glycosylation of tenomodulin can shift the molecular weight slightly, from 37 to 45 kDa, but
no higher molecular weight bands have been reported in literature and reduction of the samples
did not eliminate the bands [29].
4 Discussion
4.1 Scaffold Architecture
By tailoring tissue engineering constructs with a diverse range of signals, cellular response
can be manipulated to allow regeneration of adult tissues. For tendon, a tissue with inherent
structure, architectural cues have been shown to help maintain a characteristic phenotype in
vitro [31, 32]. While scaffold architecture has recently been shown to promote tendon cell
phenotype, fibrin gels have also been used as models for tendon tissue engineering as they
encourage cellular proliferation and ECM production [7]. The combination of scaffolds and
fibrin gel have had encouraging results for in vitro systems, however, no systematic study has
yet been done which examines the biological influence of scaffold architecture and the addition
of fibrin gels.
In this study, scaffold architecture was controlled by the mold used for ice-templating [6, 15].
Isotropic scaffolds were formed when ice nucleation occurred throughout the slurry volume,
while axial scaffolds resulted when crystals nucleated only at the base of the mold and grew
upwards [13]. Ice-templated, axial scaffolds have been shown previously in the literature to
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be significantly aligned in the longitudinal plane, and to promote an elongated tendon cell
morphology compared to isotropic scaffolds [6]. Although in the dry state, the scaffold pore
size appeared different, when hydrated, the scaffolds expanded to have pore sizes in the range
of 100 – 130 μm [15]. It is expected that the direction of cellular migration, and perhaps the
speed of migration, might be altered by the pore structure. As the pore size was not significantly
different between axial and isotropic scaffolds, the structure should not have been a barrier to
cell infiltration during the study. Altering the pore structure and the addition of fibrin gel could
also change the mechanical properties of the scaffold and potentially lead to large contraction
of scaffold constructs, triggering a loss of tendon cell viability [33]. However, no scaffold
construct contracted in any direction macroscopically, due to the relative density of the scaffolds
and the anchoring of the constructs during culture. Thus, all constructs were able to support
tendon cell proliferation and matrix production.
4.2 Evaluating Cell Proliferation and Metabolic Activity
Cell metabolic activity was not affected by scaffold architecture, but was increased significantly
with the addition of fibrin gel into scaffolds. While diffusion of the dye may be altered by
fibrin gel addition, causing an underestimation of the true metabolic activity of the tendon
cells, the results were still significantly higher on scaffolds with fibrin addition than without.
The increase in metabolic activity, corresponding to increased reduction of alamarBlue®, can
indicate either increased cellular proliferation or ECM synthesis, both of which require large
amounts of metabolic energy [34]. The decrease in metabolic activity in the fibrin control over
21 days corresponded to a tendency to dissolve over the three week period, as has been noted
in literature [10]. It seems probable that the dissolution of the gel was not matched by ECM
production, resulting in a decrease in cell number and cell metabolic activity.
The cell number within the scaffold constructs remained constant, over the culture period,
suggesting that cell death and proliferation were balanced. In some cases, there was a decrease
in cell number over the course of the study, a phenomenon which has been reported previously
in the literature [6]. The variability in cell number between constructs may be due to greater
initial cell attachment. The steady state in cell number suggests that changes in metabolic
activity may have been related to increased matrix production or remodeling in scaffolds with
fibrin gel.
4.3 Relative Contributions of Architecture and Fibrin Gel
A major aspect of tissue engineering is to encourage cells to reproduce a functional native
matrix, an ability which tendon cells can lose during in vitro culture [27, 35], and therefore
it is important to characterize the ECM produced by the cells. Although no precise tendon
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phenotype has been defined in the literature, all of the proteins examined have been cited as
markers of tendon phenotype [20, 27]. Tendon cells in all of the constructs expressed collagen
Type I, scleraxis and tenomodulin, suggesting that the tendon cell phenotype was maintained
during the study. However, the tissue engineering construct affected the relative amount of
protein marker expression.
Overall, scaffold architecture had the largest effect on protein expression, but did not influ-
ence tendon cell number or metabolic activity. Both isotropic and axial scaffold architectures
maintained tendon cell number over three weeks. Protein expression, however, was sensitive to
scaffold architecture, both with and without a fibrin gel. Tendon cells within isotropic scaffolds
produced higher amounts of both fibronectin and scleraxis than axial scaffolds. In contrast,
axial architecture stimulated tenomodulin production, which is thought to be a marker for a
mature tendon cells phenotype [20, 29]. Isotropic scaffolds may promote a less mature pheno-
type, as scleraxis is associated with the early stages of development in connective tissue, and
protein expression was not found in mature native tendon within the current study [20, 36].
Unlike scaffold architecture, addition of fibrin had a profound effect on cellular metabolism
and number, resulting in a significant increase in both. In addition, addition of a fibrin gel
influenced protein expression within scaffolds, causing a decrease in fibronectin expression
regardless of scaffold architecture. Given the supportive matrix which fibrin forms around cells,
it is likely that the cells could easily move within the gel without producing large amounts of
adhesive proteins, explaining the reduction of expression seen in Western blotting. However,
the appearance of fibronectin along the walls of scaffolds, seen in Figure 5, suggested that the
cells remained close to the pore walls, rather than moving within the pore space.
The addition of a fibrin gel to scaffolds also increased the expression of both scleraxis and
tenomodulin. Fibrin gels have been noted in literature to cause increased ECM production [10],
consistent with the findings of the current study. While expression was up-regulated regardless
of scaffold architecture, the effects of scaffold architecture were still present. Within the fibrin
gel controls, protein expression data was affected by gel degradation over the culture period.
The gel degradation added variability to protein expression data, and highlighted the improved
stability of the construct with a scaffold. This has been noted in the literature, where it has been
demonstrated that scaffolds and fibrin gels stimulate the greatest healing response when used
together [11, 12, 37].
Unlike the other proteins tested, collagen Type I content remained stable regardless of scaffold
architecture or fibrin gel addition. Gene expression differences have been noted as the culture
system moves from 2D to 3D, and with the change in environmental cues, such as the weight
percent of collagen in scaffolds [27, 33]. The results from the present study indicate that col-
lagen content is not affected by the presence or absence of a fibrin gel, or by the presence of
a supporting scaffold. Cell number appeared to be the only determiner of collagen Type I ex-
pression. Therefore, constructs which can support higher cell numbers also have an increased
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collagen Type I within the matrix, which is essential to the regeneration of tendon tissue.
Throughout the study, it was seen that architecture played an important role on cell morphology,
even in the presence of a fibrin gel. The fact that trends in protein expression were consistent
with scaffold architecture, despite fibrin gel addition, suggests that the scaffold architecture
plays a key role in regulating tendon phenotype and function. The ability of the scaffold struc-
ture to alter cellular morphology most likely drove the effects of scaffold architecture. Axial
scaffolds appeared to promote a more mature tendon cell phenotype than isotropic scaffolds,
and, indeed, other studies within tendon tissue engineering, have reported a strong link be-
tween tendon cell elongation and phenotypic gene expression [32, 38]. It has also been found
that elongated tendon cells tend to produce collagen fibers which are also aligned like native
tissue, and able to withstand much higher mechanical loading than unaligned collagen net-
works [7]. This suggests that for tendon tissue engineering, a scaffold with axial architecture
offers an advantage over isotropic scaffolds.
Addition of a fibrin gel clearly increased cell metabolic activity and cell number. Even though
fibrin gel caused an up-regulation of tendon matrix production, addition of the gel did not alter
the phenotype due to scaffold architecture. Thus, the increase in cell number promoted by
fibrin gel is independent of protein expression of cells, which is influenced by the scaffold
architecture. When used together, combinations of fibrin gel addition and scaffold architecture
can boost cell number and encourage the production of native extra cellular matrix.
5 Conclusions
Tenocytes have been cultured in scaffolds with controlled pore architectures, ranging from
isotropic to aligned, and the effects of the addition of a fibrin gel has been studied. The cell
proliferation and protein expression of tendon cells was studied over three weeks, and it was
found that both architectural cues and fibrin gel addition regulate tendon cell response inde-
pendently. While fibrin gel addition increased matrix production and led to a higher metabolic
activity and cell proliferation, the cellular phenotype appeared to be controlled by scaffold ar-
chitecture. Tendon cells in scaffolds with aligned pore structures, which mimicked the native
organization of Type I collagen, expressed higher amounts of tenomodulin, which is linked
to a mature tendon phenotype. Isotropic scaffolds promoted fibronectin and scleraxis expres-
sion. Fibrin has a positive impact on tendon cell growth and matrix synthesis, and scaffold
architecture is important for maintaining an elongated tendon cell and thus controlling the cell
phenotype. Scaffold architecture and fibrin gel have an additive effect on the tissue engineer-
ing construct and it is recommended that future constructs designed for tendon repair combine
these strategies.
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